May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Complement C5b–9, Microglia and APP Immunoreactivity in Human Retina
Author Affiliations & Notes
  • J.A. Matsubara
    Ophthal and Visual Sciences, University of British Columbia, Vancouver, BC, Canada
  • A. Seth
    Ophthal and Visual Sciences, University of British Columbia, Vancouver, BC, Canada
  • J.Z. Cui
    Ophthal and Visual Sciences, University of British Columbia, Vancouver, BC, Canada
  • Footnotes
    Commercial Relationships  J.A. Matsubara, None; A. Seth, None; J.Z. Cui, None.
  • Footnotes
    Support  CIHR
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 863. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.A. Matsubara, A. Seth, J.Z. Cui; Complement C5b–9, Microglia and APP Immunoreactivity in Human Retina . Invest. Ophthalmol. Vis. Sci. 2006;47(13):863.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Drusen contain mediators of inflammation, including amyloid beta, and components of the complement cascade (including the membrane attack complex, C5b–9). The purpose of this study is to determine the spatial relationship of activated microglia, amyloid precursor protein and C5b–9 in normal donor eye tissue.

Methods: : Immunohistochemical methods were used to identify APP, C5b–9 and activated microglia in cryostat sections of the posterior poles from normal donor eyes, less than 55 yrs (N= 15) or greater than 70 yrs of age (N=15).

Results: : Immunohistochemical staining patterns were distinct for each antibody. APP immunoreactivity was present in cytoplasmic compartment of the RPE and retinal ganglion cells. C5b–9 immunoreactivity was present in the matrix surrounding the choriocapillaris. RCA lectin binding was present in activated microglia. None of the 15 eyes less than 55 yrs of age exhibited strong C5b–9 staining, while 2 of 15 (2/15 or 13%) exhibited mild to moderate C5b–9 immunostaining. In the group of eyes greater than 70 yrs of age, 3 of 15 eyes exhibited strong, while 4 of 15 eyes exhibited mild to moderate immunostaining for C5b–9 (total 7/15 or 46%).

Conclusions: : Preliminary data suggest that C5b–9 immunoreactivity in the choriocapillaris zone increases with age in normal, donor eyes. The relationship between C5b–9, amyloid precursor protein and activated microglia in human donor eyes will be discussed.

Keywords: age-related macular degeneration • inflammation • drusen 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×